Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 5/Signature 2

EditHistoryDelete

Mark reviewed

Your review change was submitted

Needs review

Curated date: 2024/11/09

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 4: Figure S4

Description: Differentially abundant bacterial taxa between the naive and TB + HRZ groups at 4months into anti-tuberculosis HR therapy(end of therapy).

Abundance in Group 1: decreased abundance in TB +HRZ group - 4months HR(W20)

NCBI	Quality Control	Links
Dorea
Oxobacter
Ethanoligenens
Acetanaerobacterium
Anaerovorax
Ruminococcus
Mucispirillum
Roseburia
Eubacterium
Ruminiclostridium
Erysipelotrichaceae
Oscillibacter
Clostridium
Turicibacter
Coprobacter
Lachnospiraceae
Bacteroides

Revision editor(s): KateRasheed